Objective
To determine the utility (i.e., positive predictive value [PPV] and time requirement) of an adverse drug event (ADE) trigger tool in Veterans Affairs (VA) nursing homes (NHs); and to describe the most common types of potential ADEs detected with the trigger tool.
Design
Retrospective chart review.
Setting/Patients
Veterans residing in three VA NHs between 09/29/2010 and 10/29/2010.
Measurement
We used the Institute for Healthcare Improvement (IHI)-endorsed NH ADE trigger tool, modified to enhance its clinical relevance to detect potential ADEs. Electronic medical records were screened to identify residents with ≥1 abnormal laboratory value specified in the trigger tool.
Main Outcome Measures
A potential ADE was defined as the concurrent administration of medication that could cause the abnormal laboratory value. An overall PPV, or proportion of residents with an abnormal laboratory value who had a potential ADE, and average time required to complete each trigger tool assessment were calculated.
Results
Among 321 Veterans, 50.5% (n=162) had at least one abnormal laboratory value contained in the trigger tool. Ninety-nine potential ADEs involving 146 medications were detected in 65 Veterans. The overall PPV of the ADE trigger tool was 40.1% (65/162), and the average time to complete resident assessments was 8.8 (sd ± 5.7) minutes. The most common potential ADEs were acute kidney injury (n=30 residents), hypokalemia (n=18), hypoglycemia (n=13), and hyperkalemia (n=10).
Conclusions
The modified NH trigger tool was shown to be an effective and efficient method for detecting potential ADEs.
OBJECTIVES
To describe the quality of warfarin prescribing and monitoring in Veterans Affairs (VA) nursing homes and to assess the factors associated with maintaining a therapeutic International Normalized Ratio (INR).
DESIGN
Retrospective cohort.
SETTING
Five VA nursing homes.
PARTICIPANTS
All Veterans who received warfarin between January 1 and June 30, 2008 at the nursing homes.
MEASUREMENTS
Using medical records, we estimated the percentage of person-time spent in the target INR range, the proportion of patients with INRs in the therapeutic range on ≥ 50% of their person-days and the frequency of INR monitoring. We used multivariable logistic regression to identify factors associated with maintaining a therapeutic INR ≥ 50% of the time.
RESULTS
Over six months, 160 patients received 10,380 person-days of warfarin. INRs were in the therapeutic range for a majority (55%) of the person-days, and 99% of the INR tests were repeated within four weeks of the previous result. On an individual level, 49% of patients had INRs in the target range for ≥ 50% of their person-days. Achieving this outcome was more likely in patients with prevalent warfarin use versus new use (Adjusted odds ratio [AOR]=2.86; 95% confidence interval [CI]=1.06, 7.72). Conversely, patients with a history of a stroke (AOR=0.38; 95% CI=0.18, 0.80) were less likely to have therapeutic INRs for ≥ 50% of their days.
CONCLUSION
Warfarin appears to be effectively prescribed and monitored in VA nursing home patients. Future studies should focus on increasing time in therapeutic range among patients with poor INR control.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.